HomeMYX • ASX
Follow
Mayne Pharma Group Ltd
Previous close
$7.22
Day range
$7.10 - $7.32
Year range
$2.75 - $7.35
Market cap
615.94M AUD
Avg Volume
256.60K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 93.96M | 259.80% |
Operating expense | 71.86M | 19.00% |
Net income | -35.28M | -124.33% |
Net profit margin | -37.54 | -106.76% |
Earnings per share | — | — |
EBITDA | -2.28M | 93.90% |
Effective tax rate | 5.76% | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 154.81M | -11.81% |
Total assets | 1.15B | -22.83% |
Total liabilities | 604.88M | -13.02% |
Total equity | 547.77M | — |
Shares outstanding | 81.25M | — |
Price to book | 1.07 | — |
Return on assets | -4.11% | — |
Return on capital | -8.11% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -35.28M | -124.33% |
Cash from operations | -14.36M | 49.44% |
Cash from investing | 33.60M | -85.94% |
Cash from financing | -10.10M | 94.04% |
Net change in cash | 8.31M | -78.94% |
Free cash flow | -703.62K | 99.43% |
About
Founded
2005
Website
Employees
900